NASH and Nutritional Therapy
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Tokyo :
Springer Tokyo,
2005.
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Nonalcoholic Fatty Liver (NAFL): Overview
- Role of Leptin in Pathogenesis of NASH
- Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis
- Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH)
- Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH
- Clinical Features of Patients with Nonalcoholic Fatty Liver Disease
- Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH)
- Mammalian Target of Rapamycin (mTOR)
- Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of Cirrhosis
- Nutritional Therapy in Patients with Liver Cirrhosis.